Allergic Reaction

Although this year brought many advances in the treatment of food allergy, the FDA’s approval of omalizumab dominated our most popular coverage.

This year brought breakthroughs and important advances in asthma and allergy. Healio’s most popular stories in 2024 covered the long-anticipated approval of neffy epinephrine nasal spray and an update to anaphylaxis practice parameters.

BOSTON — A study in Honduras shows food sensitization is common among children there, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Anaphylaxis protocols in emergency medical services have outdated recommendations and guidelines, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

In a Healio Expert Submission, Douglas H. Jones, MD, FAAAAI, FACAAI, discussed currently available food allergy treatments and some that are in development.

Adolescents and young adults reported being less comfortable managing their allergy around their peers than with their families, according to a study published in The Journal of Allergy and Clinical Immunology.

DBV Technologies recently provided updates on its Viaskin Peanut Program for children and toddlers, announcing recruitment for the VITESSE study and progress in the COMFORT Toddlers supplemental safety study.

Participants with an allergy to cow’s milk had the lowest rate of oral immunotherapy treatment discontinuation, according to a study published in Annals of Allergy, Asthma and Immunology.

As asthma and allergy continue to affect more people, the importance of advanced practitioners in enhancing patient safety, addressing health care disparities and increasing treatment access has come to the forefront of patient care.